A study by Li et al. showed that downregulation of SIRT4 in TAMs regulates macrophage alternative activation and aids in the development of HCC through the fatty acid oxidation (FAO)–PPAR–STAT3 axis. This evidence concerns the gene STAT3 and hepatocellular carcinoma.